This white paper provides Medical Affairs professionals with the background and history of Real-World Evidence, and its applications in the biopharma industry to benefit patients.
How do leaders make their way to Medical Safety & Pharmacovigilance? The routes are diverse but one constant remains true: They are extremely committed to being an independent voice that amplifies their organization’s commitment to Patient Centricity.
Digitalization offers Medical Affairs teams the opportunity to rethink strategy and actions across the lifecycle of traditional and nontraditional products.
This podcast previews the MAPS 2022 Global Annual Meeting session “How Medical Affairs can best support internal and external collaborations in patient engagement,” that details the unique role of Medical Affairs in patient engagement.
One of the pandemic’s silver linings may well be gains in participation levels and the volume and quality of insights generated by eliminating the constraints of face-to-face interaction.
In this podcast, we speak with presenters of the MAPS 2022 Global Annual Meeting session, “Developing and Executing and Integrated Medical Communications Strategy and Plan.”
This podcast, part two of a two-part series, discusses practical tips on how to incorporate cybersecurity into your own practices and devices.
In this final article in the Leadership Perspectives series, John Pracyk interviews J&J leaders to explore a bold vision of career development that entails moving across sectors; namely, crossing over between Pharmaceuticals, Medical Devices, Vision, and Consumer Health.
Pharmaceutical teams need a different way to approach working virtually. The secret isn’t adding more virtual calls, but unlocking the strategic power of virtual work. Download this white paper to see how your peers are achieving more, with fewer meetings.
In conversation with John Pracyk, MD, PhD, MBA, Medical Affairs leaders from Johnson & Johnson describe best practices to prepare our next generation of Chief Medical Officers.